Celmatix

A preclinical-stage women’s health biotech focused uniquely on ovarian biology.

[Celmatix @celmatix]

@DDNewsOnline's @NatOrtolano interviews our CEO Dr. @pirayebeim in headlining article "Is Anti-Müllerian Hormone the New Estrogen?" https://t.co/wefk1OgjL9 #WomensHealth #biotech

[Celmatix @celmatix]

A comprehensive look at discussions on #menopause by @FastCompany's @ainsleyoc featuring @celmatix "One of the biggest lies in healthcare today is that menopause is a natural phenomenon"...@pirayebeim says. In her eyes, it’s a “public health crisis.”
https://t.co/fZt8kh6Iyr

[Celmatix @celmatix]

We regularly discuss the complicated health toll of #menopause on women, now a new study from @MayoClinic uncovers a sizable financial toll as well. Findings reveal menopause is estimated to cost $1.8 billion in the US annually #endmenopause https://t.co/WDlwBPzYXp

[Celmatix @celmatix]

Wonderful to be included in @NewYorker's “The Future of Fertility” piece this month w/ @celmatix Founder @pirayebeim's perspective on what the future of #fertility could truly hold, & the critical work needed to address women's reproductive longevity.
https://t.co/z9eB85zpJm

[Celmatix @celmatix]

Our founder, Dr. @pirayebeim shares why Celmatix is focused on #ovarian health, extending ovarian function, and importantly ending #menopause.

#womenshealth

[SHE Media @SheKnowsMedia]

SHE Media Co-lab Speaker + Founder of @Celmatix Dr. @PirayeBeim calls for an end to #menopause. See what else she had to say about #ovarianhealth alongside Dr @JShepherd_MD + SHE Media VP, Video
@reshingbull at our Future of Health event at @SXSW®.

📷: https://t.co/OJFfZMVjrz

[Femtech Insider @femtechinsider]

🚀 Biotech company @Celmatix launches novel PCOS drug program targeting melatonin receptors

More on this: https://t.co/JHXZFjJuaP

#biotech #pcos #ovarianbiology

[Celmatix @celmatix]

Celmatix's #melatonin drug program addresses a critical gap in the market for effective treatments for a range of women’s health indications, starting w/ #PCOS, w/ the potential to expand into the treatment of #endometriosis and #menopausal symptoms. https://t.co/7PUCRelbbS

[Celmatix @celmatix]

A behind-the-scenes look at today's interview w/ @OprahDaily as @pirayebeim shares more on the role of the #ovary & why @celmatix is working to end #menopause. We're excited for the interview to come out next week along w/ other announcements from our team. Stay tuned!

[Celmatix @celmatix]

Proud to be a part of the largest study on #endometriosis #genetics conducted to date.

[Nature Genetics @NatureGenet]

‼️ OUT TODAY @NatureGenet
📰 The genetic basis of #endometriosis and comorbidity with other pain and inflammatory conditions
🧑🏽‍🤝‍🧑🏼 @Nilosh @KrinaZondervan @Ox_wrh
and colleagues
⬇️
https://t.co/ht0SdzTrOU

[Celmatix @celmatix]

Celmatix & collaborators announced findings today in @NatureGenet on the #genetic basis of #endometriosis. Research reveals a shared #genetic basis for endometriosis and other types of pain seemingly unrelated to endometriosis. Read more here:https://t.co/IuOLsyHM80

[Celmatix @celmatix]

The #changemakers issue from @iamwellandgood features @celmatix founder and CEO, Dr. Piraye Yurttas Beim as a founder driving real progress in #womenshealth. We're proud to be included in their series on the future of wellness.
https://t.co/3ERMqQLDMB

[Celmatix @celmatix]

Excited to join the speakers @SheKnowsMedia #SXSW w/@katiecouric, @CTurlington & others. @pirayebeim will speak on #menopause & longevity & how @Celmatix is working to extend ovarian function w/ groundbreaking #therapeutics.
https://t.co/3jhjRA3ev8

[Celmatix @celmatix]

Excited to announce the opening of our Cambridge/Boston office in Kendall Square at @CICcambridge

[Celmatix @celmatix]

Dr. @pirayebeim speaking today at @LongwoodFund's #longwoodhealthcareleaders event alongside #biotech execs from @Organon, @unicycive, @ConcertPharma, @OcuTerra, & others https://t.co/1waJxTk443 @shalabhguptamd @DrGFiore

[Celmatix @celmatix]

@Forbes' @MarijaButkovic interviews our CEO Dr. @pirayebeim on why we coined #ovarianhealth, and our AMH drug program and it's potential in #menopause https://t.co/eZ27Jy6W6j #WomensHealth #Biotechnology

[Femtech Insider @femtechinsider]

🧬 @celmatix, @bayer & @Evotec just hit another milestone in their quest to develop a first-in-class drug for #PCOS

💬"Novel PCOS drug target progresses into hit-identification."

Full story: https://t.co/pp9DS6nPTT

#womenshealth #biotech

[Celmatix @celmatix]

Validation of our 1st #pcos #drugdiscovery program by our partners at @Evotec and @Bayer #womenshealth
https://t.co/YdAqosKVoJ

[eCornell @ecornell_online]

Many modern-day #innovations are born in the #lab.

On 09/08 @ 1 PM ET, join @AtomwiseInc's Abraham Heifets, @CornellEng's Andrea Ippolito, @StrandTx's Jacob Becraft, and @celmatix's Piraye Beim to hear their journeys from #science to #startups: https://t.co/jiRrsCXIbr

[Celmatix @celmatix]

@Forbes recognizes us as a leading #woman-led #startup driving the #future of #healthtech + #femtech. The #futureisfemale! https://t.co/tPUgTITKqq @WomenWhoTech

[Celmatix @celmatix]

@FierceBiotech's @amirahalidrus covers @merckgroup vet + new @celmatix CSO Dr. Palmer & our arc as a #WomensHealth #drugdiscovery #biotech https://t.co/biGn4rSzEz